Name | BI 456906 |
---|
Description | BI 456906 is a dual-acting agonist of glucagon-like peptide 1 (GLP-1) receptor and glucagon receptor. BI 456906 can be used for the research of obesity and non-alcoholic steatohepatitis (NASH)[1][2]. |
---|---|
Related Catalog | |
In Vitro | BI 456906 potentiates glucose-stimulated insulin secretion from rodent and perifused human islets and potently inhibits glycogen synthesis[2]. |
In Vivo | BI 456906 reduces food intake, gastric emptying, and improvements in oral glucose tolerance in dose-dependent in single administration to lean mice[2]. BI 456906 led to bodyweight-lowing in DIO mice[2]. |
References |
No Any Chemical & Physical Properties |